Evidence map›Paper›PMID 28249834›Full record

ArticleJMIR mHealth and uHealth2017

Efficacy of Mobile Apps to Support the Care of Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Bráulio Cezar Bonoto, Vânia Eloisa de Araújo, Isabella Piassi Godói, Lívia Lovato Pires de Lemos, Brian Godman, Marion Bennie, Leonardo Mauricio Diniz, Augusto Afonso Guerra Junior

3 registry-linked trialsOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JMIR mHealth and uHealth, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 162 papers, 22 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
162citing papers in PubMed, 22 pooled it
63.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03516864 unknown statusnot on this mapstarted 2018, after this paper: background citation

Assessment of Tissue Oxygenation Using Multispectral Imaging

TypeobservationalSponsorUnity Health TorontoRan2018 to 2019Enrolled12ConditionsDiabetes MellitusArmsMIMOSA Imager, Kent Camera
NCT03998267 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Qatar Diabetes Mobile Application Trial

TypeinterventionalSponsorHamad Medical CorporationRan2019 to 2020Enrolled180ConditionsType2 Diabetes MellitusArmsDroobi, Standard of care
NCT05893927 narecruitingnot on this mapstarted 2024, after this paper: background citation

Evaluating the Clinical Impact of a PCP Developed Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes

TypeinterventionalSponsorThe Reading Hospital and Medical CenterRan2024 to 2026Enrolled65ConditionsDiabetes Mellitus, Type 2, Diabetes Education, Lifestyle ModificationArmsDiabetes education web site application
3 · Its place in the literature

Who cites it

162 citing papers in PubMed, 22 syntheses or guidelines pooled it, 318 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Efficacy of eHealth Interventions for Adults with Diabetes: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2021
    Pooled it
  13. A Systematic Review on Mobile Health Applications' Education Program for Patients Taking Oral Anticoagulants.International journal of environmental research and public health · 2021
    Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Pooled it
  19. The effectiveness of app-based mobile interventions on nutrition behaviours and nutrition-related health outcomes: A systematic review and meta-analysis.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2019
    Pooled it
  20. Pooled it

102 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Bráulio Cezar BonotoPost Graduate Program in Medicines and Pharmaceutical Assistance, Department of Social Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.ORCID http://orcid.org/0000-0001-7514-2407
Vânia Eloisa de AraújoInstitute of Biological Sciences and Health, Faculty of Odontology, Pontifícia Universidade Católica de Minas Gerais, Belo Horizonte, Brazil.ORCID http://orcid.org/0000-0002-0345-8522
Isabella Piassi GodóiPost Graduate Program in Medicines and Pharmaceutical Assistance, Department of Social Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.ORCID http://orcid.org/0000-0002-0568-6625
Lívia Lovato Pires de LemosSUS Collaborating Centre for Technology Assessment and Excellence in Health, Department of Social Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.ORCID http://orcid.org/0000-0002-8921-515X
Brian GodmanInstitute of Pharmacy and Biomedical Sciences, University of Strathclyde Glasgow, Glasgow, United Kingdom.ORCID http://orcid.org/0000-0001-6539-6972
Marion BennieInstitute of Pharmacy and Biomedical Sciences, University of Strathclyde Glasgow, Glasgow, United Kingdom.ORCID http://orcid.org/0000-0002-4046-629X
Leonardo Mauricio DinizDepartment of Clinical Medicine, Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.ORCID http://orcid.org/0000-0001-9651-8485
Augusto Afonso Guerra JuniorPost Graduate Program in Medicines and Pharmaceutical Assistance, Department of Social Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.ORCID http://orcid.org/0000-0001-5256-0577
Universidade Federal de Minas Gerais · BRKarolinska University Hospital · SEPontifícia Universidade Católica de Minas Gerais · BRUniversity of Strathclyde · GB

Funding

Medical Research Council MR/K007017/1
6 · The paper itself

Abstract

backgroundDiabetes Mellitus (DM) is a chronic disease that is considered a global public health problem. Education and self-monitoring by diabetic patients help to optimize and make possible a satisfactory metabolic control enabling improved management and reduced morbidity and mortality. The global growth in the use of mobile phones makes them a powerful platform to help provide tailored health, delivered conveniently to patients through health apps.

objectiveThe aim of our study was to evaluate the efficacy of mobile apps through a systematic review and meta-analysis to assist DM patients in treatment.

methodsWe conducted searches in the electronic databases MEDLINE (Pubmed), Cochrane Register of Controlled Trials (CENTRAL), and LILACS (Latin American and Caribbean Health Sciences Literature), including manual search in references of publications that included systematic reviews, specialized journals, and gray literature. We considered eligible randomized controlled trials (RCTs) conducted after 2008 with participants of all ages, patients with DM, and users of apps to help manage the disease. The meta-analysis of glycated hemoglobin (HbA1c) was performed in Review Manager software version 5.3.

resultsThe literature search identified 1236 publications. Of these, 13 studies were included that evaluated 1263 patients. In 6 RCTs, there were a statistical significant reduction (P<.05) of HbA1c at the end of studies in the intervention group. The HbA1c data were evaluated by meta-analysis with the following results (mean difference, MD -0.44; CI: -0.59 to -0.29; P<.001; I²=32%).The evaluation favored the treatment in patients who used apps without significant heterogeneity.

conclusionsThe use of apps by diabetic patients could help improve the control of HbA1c. In addition, the apps seem to strengthen the perception of self-care by contributing better information and health education to patients. Patients also become more self-confident to deal with their diabetes, mainly by reducing their fear of not knowing how to deal with potential hypoglycemic episodes that may occur.

Indexed as

diabetes mellitusmobile applicationsself-caretelemedicine

Identifiers

PMID28249834
PMCPMC5352856
OpenAlexW2592184816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.